Ramosetron
- Generic Name
- Ramosetron
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H17N3O
- CAS Number
- 132036-88-5
- Unique Ingredient Identifier
- 7ZRO0SC54Y
- Background
Ramosetron is a serotonin 5-HT3 receptor antagonist commonly employed to treat nausea and vomiting, in addition to certain diarrheal conditions. It is believed to have higher potency and longer antiemetic action than other 1st generation 5-HT3 antagonists such as ondansetron. Currently, ramosetron is only approved for use Japan and in certain Southeast Asian...
- Indication
For the treatment of nausea and vomiting and diarrhea-predominant irritable bowel syndrome in males.
- Associated Conditions
- Gastrointestinal Symptoms caused by cancer treatment
- Associated Therapies
- -
Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-09-03
- Last Posted Date
- 2011-02-28
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 172
- Registration Number
- NCT00971399
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 98
- Registration Number
- NCT00918411
A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea
- First Posted Date
- 2006-01-05
- Last Posted Date
- 2017-03-09
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 287
- Registration Number
- NCT00272285
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath